Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Total Current Liabilities (2024 - 2026)

Updated

Seaport Therapeutics (SPTX) reported Total Current Liabilities of $17.11 million for Q3 2026, up 9.1% from the prior quarter.

Analysis

Seaport Therapeutics (SPTX) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Seaport Therapeutics posted Total Current Liabilities of $12.78 million, up 14.6% from FY2024.

  • By year, Total Current Liabilities came in at $11.15 million in FY2024.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $15.67 million (Q2 2026), $14.22 million (Q1 2026) and $12.78 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 47.00 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 55.46 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 43.10 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 28.80 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -31.27 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 23.23 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 12.00 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 31.73 Bn
10 Seaport Therapeutics 1.03 Bn 63.31 Mn - 17.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17.11 Mn
Jun 30, 2026 15.67 Mn
Mar 31, 2026 14.22 Mn
Dec 31, 2025 12.78 Mn
Dec 31, 2024 11.15 Mn
API Access

Seaport Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SPTX&period=max&api_key=YOUR_API_KEY